Author/Authors :
Aminimoghaddam، Soheila نويسنده Assistant Professor of Obstetrics and Gynecology, Firoozgar Hospital , , Yarandi، Fariba نويسنده , , Nejadsalami، Forough نويسنده Resident of Obstetrics and Gynecology , , Taftachi، Farrokh نويسنده Assistant Professor of Legal Medicine , , Noor bakhsh، Fereshteh نويسنده Resident of Obstetrics and Gynecology , , Mahmoudzadeh، Fatemeh نويسنده Medical student ,
Abstract :
Background: Gestational trophoblastic neoplasia (GTN) disease is excessive and inappropriate proliferation of trophoblast after termination of the pregnancy. Many attempts have been made to improve follow-up proce-dures, but no studies have evaluated Human Chorionic Gonadotrophin (HCG) as a post treatment indicator. Thus we aimed to know B-HCG variability in post treatment pregnancies.
Methods: 40 Molar affected pregnancies were followed post-surgical treatment by serum B-HCG level in a tertiary level hospital. All subjects were treated by evacuation and followed by B-HCG every week for three weeks, then every month for six months.
Results: 30 women were normal (group I) and 10 (group II) diagnosed as GTN cases. Serum B-HCG which obtained serially shown significant differences between two groups (p=0.001). The quantity of B-HCG/week had significantly higher level than normal females (p < 0.001)
Conclusion: Our results suggested that B-HCG serum level could be used as a strong indicator for identifying affected patients at early stage.
